SCHEMBL29317391

SCHEMBL29317391

CC(CC(C)(C)C(=O)O)C(=O)OCCOCCN

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 2/20 0.32
ACACB O00763 1/20 0.30
ACACA Q13085 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16438140 0.80 ACACB (0.39) ACACBACACA
SCHEMBL12392803 0.75 MEN1 (0.32)
SCHEMBL2617898 0.74 MMP8 (0.40) ACACBACACA
SCHEMBL29328186 0.74
SCHEMBL6064079 0.73 CYP4F2 (0.39) ACACBACACA
SCHEMBL19263668 0.73
SCHEMBL17278939 0.72 ACACB (0.37) ACACBACACA
SCHEMBL13345987 0.72 ALDH1A1 (0.44) ACACBACACA
SCHEMBL26338020 0.72 ALDH1A1 (0.37) GABRR1
SCHEMBL23870936 0.71 ALDH1A1 (0.33) GABRR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024146920-A1 DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS ASCENDIS PHARMA OPHTHALMOLOGY DIVISION A/S (DK) 2024-07-11 WO disclosed